Spatial Genomics and Transcriptomics Market to be dominated by Spatial Transcriptomics through 2028.
The advancements in sequencing technology are expected
to drive the growth of Global Spatial Genomics and Transcriptomics during the
forecast period, 2024-2028.
According to TechSci Research report, “Spatial Genomics and Transcriptomics Market - Global
Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”, Global Spatial Genomics and Transcriptomics Market is anticipated to
grow at an impressive rate in the forecast period, 2024-2028. This can
be ascribed to the increasing demand for personalized medicine, rising
investment in research and development, and the growing prevalence of chronic
diseases. Additionally, growing applications of spatial genomics and
transcriptomics include cancer diagnosis, drug discovery, developmental
biology, and neurology. Also, the increasing adoption of advanced technologies
and the presence of key market players will further boost the growth of the Global
Spatial Genomics And Transcriptomics Market in the forecast period.
However, high cost
of instruments and consumables for spatial genomics and transcriptomics along
with lack of standardization of spatial genomics and transcriptomics may slow
down the growth of the market in the forecast period. Also, Spatial genomics
and transcriptomics generate large amount of data, which can be complex and
difficult to analyze excluding experts that can further restrict the growth of the
Global Spatial Genomics and Transcriptomics Market.
Browse over XX market data
Figures spread through xx
Pages and an in-depth TOC on "Global Spatial Genomics and Transcriptomics Market”
Spatial Genomics and Transcriptomics
Market can be segmented by technique, product type, application, end user and
region.
Based on application, the Global Spatial
Genomics and Transcriptomics Market can be divided into Translational
Research, Drug discovery & development. Translational research dominated the market
in 2022 and is expected to continue maintaining its dominance throughout the
forecast period. This can be ascribed to increasing use of spatial genomics and
transcriptomics in translational research to determine high-throughput data of
cells and tissues to understand physiology and development of novel and
advanced diagnostic tools and different therapeutic approaches. Also, increasing
involvement and investment by key players of the market to develop predictive
tests for early diagnosis of chronic conditions is expected to further drive the
growth of the market during the forecast period.
Based on Technique, the market can be divided into spatial
transcriptomics and spatial genomics analysis. The spatial transcriptomics segment is
expected to dominate during the forecast period on account of the increasing
demand for advanced sequencing technologies for development of novel drugs and high rate of adoption of in-situ
sequencing techniques in the research institutes and laboratories. Increasing
transcriptomic studies of single cells in laboratory and research institutes
for drug discovery and development processes for efficient disease management. Also,
advancement in genomic research and discovery of genome editing tools such as
CRISPR/Cas9 system is expected to create a lucrative growth during the forecast
period.
Major companies operating in the global Spatial
Genomics and Transcriptomics market are:
- 10X Genomics Inc.
- Akoya Bioscience Ltd.
- Biospyder Technologies Inc.
- BioTechne Corporation.
- Dovetail Genomics LLC.
- Fluidigm Corporation.
- Genomic Vision SA.
- Illumina Inc.
- Lunaphore Technologies SA.
- Nanostring Technolgies Inc.
In March 2021, Rebus Biosystems announced the launch of
new “spatial omics” system, which will enable researchers to gain a detailed
view of output of individual cells in wide range of tissue samples. The system
integrates single-molecule fluorescence in-situ hybridization or smFISH
chemistry techniques to study gene and RNA expression in their original
locations.
In August 2020, NanoString Technologies, Inc., which is a
globally recognized provider of life science tools for translation research,
announced its partnership with Illumina, Inc. for the commercial launch of
first GeoMx DSP Read-Out for Next Generation Sequencing (NGS). The company is
aiming to offer a wide portfolio of spatially resolved RNA and protein assays
that cover everything from targeted content to whole transcriptome panels.
Download Free Sample Report
Customers can also request
for 10% free customization on this report.
“North
America is expected to dominate the Global Spatial Genomics and Transcriptomics
market due to the strong presence of major key players focusing on development
of advanced genomics and proteomics along with growing focus on genomics and
proteomics research for the development of novel drugs which will diagnose the chronic
diseases across the region. Similarly, the increasing investments by government
bodies for expanding the research across the globe and private organizations are
supporting for genome research in the region Furthermore, the increasing demand
for personalized medicine which will be needed for quality checking and the
growing focus on precision medicine are the major factors driving the growth of
the market during the forecast period. Besides, increasing development of better
healthcare infrastructure and growing focuses on the modernization of
treatments is further expected to create lucrative opportunities for market
growth” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based
global management consulting firm.
“Spatial Genomics and
Transcriptomics Market
- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F” Segmented By Technique (Spatial Transcriptomics v/s Spatial Genomics
Analysis), By Product Type (Instruments, Consumables, Software), By Application
(Translational Research v/s Drug discovery & development), By End User
(Pharmaceutical & Biotechnology companies, Contract Research Organizations,
Academic & Research Institutes) and By Region and Competition”, has evaluated the future growth potential of global Spatial
Genomics and Transcriptomics market and provides statistics & information
on market size, structure, and future market growth. The report intends to
provide cutting-edge market intelligence and help decision-makers take sound
investment decisions. Besides, the report also identifies and analyzes the
emerging trends along with essential drivers, challenges, and opportunities in the
Global Spatial Genomics and Transcriptomics market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web: https://www.techsciresearch.com